Identification of a gene encoding a melanoma tumor antigen recognized by HLA-A31-restricted tumor-infiltrating lymphocytes [published erratum appears in J Exp Med 1995 Mar 1;181(3):1261]

doi:10.1084/jem.181.2.799

This Article

Full Text (PDF)

Alert me when this article is cited

Citation Map

Services

Email this article

Similar articles in this journal

Similar articles in PubMed

Alert me to new content in the JEM

Download to citation manager

Citing Articles

Citing Articles via HighWire

Citing Articles via CrossRef

Citing Articles via Google Scholar

Google Scholar

Articles by Wang, R. F.

Articles by Rosenberg, S. A.

Search for Related Content

PubMed

PubMed Citation

Articles by Wang, R. F.

Articles by Rosenberg, S. A.

Pubmed/NCBI databases

Medline Plus Health Information
Melanoma

Social Bookmarking

What's this?

ARTICLES

Identification of a gene encoding a melanoma tumor antigen recognized by HLA-A31-restricted tumor-infiltrating lymphocytes [published erratum appears in J Exp Med 1995 Mar 1;181(3):1261]

RF Wang, PF Robbins, Y Kawakami, XQ Kang and SA Rosenberg
Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892.

The availability of antitumor cytotoxic T lymphocytes which can be generated from either peripheral blood lymphocytes after stimulation in vitro or tumor infiltrating lymphocytes (TIL) has made it possible to identify a number of melanoma antigens presented by major histocompatibility complex class I molecules. The present and previous studies indicated that TIL586 recognized an antigen expressed on most melanoma and normal melanocytes in the context of the HLA-A31 molecule. We report here the cloning of a cDNA that directs the expression of the shared melanoma antigen recognized by this TIL. The DNA sequence analysis revealed that the cDNA was almost identical to the gene encoding tyrosinase-related protein 1 or glycoprotein gp75 which was originally identified by serum antibodies in a patient with melanoma. The gene was found to be expressed only in melanoma, normal melanocyte cell lines, and retina, but not in other normal tissues tested. The gp75 antigen presented by HLA-A31 may therefore constitute a useful immune target for specific treatment of patients with melanoma, since both antibody- and T cell-mediated immune responses can be generated against this antigen.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

Wang, R.-F. (2006). Regulatory T cells and toll-like receptors in cancer therapy.. Cancer Res. 66: 4987-4990 [Abstract] [Full Text]
Peng, G., Guo, Z., Kiniwa, Y., Voo, K. s., Peng, W., Fu, T., Wang, D. Y., Li, Y., Wang, H. Y., Wang, R.-F. (2005). Toll-Like Receptor 8-Mediated Reversal of CD4+ Regulatory T Cell Function. Science 309: 1380-1384 [Abstract] [Full Text]
Craft, N., Bruhn, K. W., Nguyen, B. D., Prins, R., Lin, J. W., Liau, L. M., Miller, J. F. (2005). The TLR7 Agonist Imiquimod Enhances the Anti-Melanoma Effects of a Recombinant Listeria monocytogenes Vaccine. J. Immunol. 175: 1983-1990 [Abstract] [Full Text]
van Dinten, L. C., Pul, N., van Nieuwpoort, A. F., Out, C. J., Jager, M. J., van den Elsen, P. J. (2005). Uveal and Cutaneous Melanoma: Shared Expression Characteristics of Melanoma-Associated Antigens. IOVS 46: 24-30 [Abstract] [Full Text]
Matsuo, M., Nagata, Y., Sato, E., Atanackovic, D., Valmori, D., Chen, Y.-T., Ritter, G., Mellman, I., Old, L. J., Gnjatic, S. (2004). IFN-{gamma} enables cross-presentation of exogenous protein antigen in human Langerhans cells by potentiating maturation. Proc. Natl. Acad. Sci. USA 101: 14467-14472 [Abstract] [Full Text]
Ruiz, M., Kobayashi, H., Lasarte, J. J., Prieto, J., Borras-Cuesta, F., Celis, E., Sarobe, P. (2004). Identification and Characterization of a T-Helper Peptide from Carcinoembryonic Antigen. Clin. Cancer Res. 10: 2860-2867 [Abstract] [Full Text]
de Rijke, B., Fredrix, H., Zoetbrood, A., Scherpen, F., Witteveen, H., de Witte, T., van de Wiel-van Kemenade, E., Dolstra, H. (2003). Generation of autologous cytotoxic and helper T-cell responses against the B-cell leukemia-associated antigen HB-1: relevance for precursor B-ALL-specific immunotherapy. Blood 102: 2885-2891 [Abstract] [Full Text]
Matsui, K., O'Mara, L. A., Allen, P. M. (2003). Successful elimination of large established tumors and avoidance of antigen-loss variants by aggressive adoptive T cell immunotherapy. Int Immunol 15: 797-805 [Abstract] [Full Text]
Horiguchi, Y., Nukaya, I., Okazawa, K., Kawashima, I., Fikes, J., Sette, A., Tachibana, M., Takesako, K., Murai, M. (2002). Screening of HLA-A24-restricted Epitope Peptides from Prostate-specific Membrane Antigen That Induce Specific Antitumor Cytotoxic T Lymphocytes. Clin. Cancer Res. 8: 3885-3892 [Abstract] [Full Text]
Espinoza-Delgado, I. (2002). Cancer Vaccines. The Oncologist 7: 20-33 [Abstract] [Full Text]
Sosman, J. A., Unger, J. M., Liu, P.-Y., Flaherty, L. E., Park, M. S., Kempf, R. A., Thompson, J. A., Terasaki, P. I., Sondak, V. K. (2002). Adjuvant Immunotherapy of Resected, Intermediate-Thickness, Node-Negative Melanoma With an Allogeneic Tumor Vaccine: Impact of HLA Class I Antigen Expression on Outcome. JCO 20: 2067-2075 [Abstract] [Full Text]
Khong, H. T., Rosenberg, S. A. (2002). Pre-Existing Immunity to Tyrosinase-Related Protein (TRP)-2, a New TRP-2 Isoform, and the NY-ESO-1 Melanoma Antigen in a Patient with a Dramatic Response to Immunotherapy. J. Immunol. 168: 951-956 [Abstract] [Full Text]
Mullins, D. W., Bullock, T. N. J., Colella, T. A., Robila, V. V., Engelhard, V. H. (2001). Immune Responses to the HLA-A*0201-Restricted Epitopes of Tyrosinase and Glycoprotein 100 Enable Control of Melanoma Outgrowth in HLA-A*0201-Transgenic Mice. J. Immunol. 167: 4853-4860 [Abstract] [Full Text]
Zeng, G., Wang, X., Robbins, P. F., Rosenberg, S. A., Wang, R.-F. (2001). CD4+ T cell recognition of MHC class II-restricted epitopes from NY-ESO-1 presented by a prevalent HLA DP4 allele: Association with NY-ESO-1 antibody production. Proc. Natl. Acad. Sci. USA 10.1073/pnas.061507398v1 [Abstract] [Full Text]
Jäger, D., Stockert, E., Güre, A. O., Scanlan, M. J., Karbach, J., Jäger, E., Knuth, A., Old, L. J., Chen, Y.-T. (2001). Identification of a Tissue-specific Putative Transcription Factor in Breast Tissue by Serological Screening of a Breast Cancer Library. Cancer Res. 61: 2055-2061 [Abstract] [Full Text]
Kawakami, Y., Wang, X., Shofuda, T., Sumimoto, H., Tupesis, J. P., Fitzgerald, E., Rosenberg, S. A. (2001). Isolation of a New Melanoma Antigen, MART-2, Containing a Mutated Epitope Recognized by Autologous Tumor-Infiltrating T Lymphocytes. J. Immunol. 166: 2871-2877 [Abstract] [Full Text]
Jäger, D., Stockert, E., Jäger, E., Güre, A. O., Scanlan, M. J., Knuth, A., Old, L. J., Chen, Y.-T. (2000). Serological Cloning of a Melanocyte rab Guanosine 5'-Triphosphate-binding Protein and a Chromosome Condensation Protein from a Melanoma Complementary DNA Library. Cancer Res. 60: 3584-3591 [Abstract] [Full Text]
Colella, T. A., Bullock, T. N.J., Russell, L. B., Mullins, D. W., Overwijk, W. W., Luckey, C. J., Pierce, R. A., Restifo, N. P., Engelhard, V. H. (2000). Self-Tolerance to the Murine Homologue of a Tyrosinase-derived Melanoma Antigen: Implications for Tumor Immunotherapy. J. Exp. Med. 191: 1221-1232 [Abstract] [Full Text]
Wang, F., Bade, E., Kuniyoshi, C., Spears, L., Jeffery, G., Marty, V., Groshen, S., Weber, J. (1999). Phase I Trial of a MART-1 Peptide Vaccine with Incomplete Freund's Adjuvant for Resected High-Risk Melanoma. Clin. Cancer Res. 5: 2756-2765 [Abstract] [Full Text]
Ronsin, C., Chung-Scott, V., Poullion, I., Aknouche, N., Gaudin, C., Triebel, F. (1999). A Non-AUG-Defined Alternative Open Reading Frame of the Intestinal Carboxyl Esterase mRNA Generates an Epitope Recognized by Renal Cell Carcinoma-Reactive Tumor-Infiltrating Lymphocytes In Situ. J. Immunol. 163: 483-490 [Abstract] [Full Text]
Tanzarella, S., Russo, V., Lionello, I., Dalerba, P., Rigatti, D., Bordignon, C., Traversari, C. (1999). Identification of a Promiscuous T-Cell Epitope Encoded by Multiple Members of the MAGE Family. Cancer Res. 59: 2668-2674 [Abstract] [Full Text]
Wang, R., Wang, X., Atwood, A. C., Topalian, S. L., Rosenberg, S. A. (1999). Cloning Genes Encoding MHC Class II-Restricted Antigens: Mutated CDC27 as a Tumor Antigen. Science 284: 1351-1354 [Abstract] [Full Text]
Hirschowitz, E. A., Crystal, R. G. (1999). Adenovirus-Mediated Expression of Interleukin-12 Induces Natural Killer Cell Activity and Complements Adenovirus-Directed gp75 Treatment of Melanoma Lung Metastases. Am. J. Respir. Cell Mol. Bio. 20: 935-941 [Abstract] [Full Text]
Maitre, N., Brown, J. M., Demcheva, M., Kelley, J. R., Lockett, M. A., Vournakis, J., Cole, D. J. (1999). Primary T-Cell and Activated Macrophage Response Associated with Tumor Protection Using Peptide/Poly-N-Acetyl Glucosamine Vaccination. Clin. Cancer Res. 5: 1173-1182 [Abstract] [Full Text]
Men, Y., Miconnet, I., Valmori, D., Rimoldi, D., Cerottini, J.-C., Romero, P. (1999). Assessment of Immunogenicity of Human Melan-A Peptide Analogues in HLA-A*0201/Kb Transgenic Mice. J. Immunol. 162: 3566-3573 [Abstract] [Full Text]
Greten, T. F., Jaffee, E. M. (1999). Cancer Vaccines. JCO 17: 1047-1047 [Abstract] [Full Text]
Kawakami, Y., Robbins, P. F., Wang, X., Tupesis, J. P., Parkhurst, M. R., Kang, X., Sakaguchi, K., Appella, E., Rosenberg, S. A. (1998). Identification of New Melanoma Epitopes on Melanosomal Proteins Recognized by Tumor Infiltrating T Lymphocytes Restricted by HLA-A1, -A2, and -A3 Alleles. J. Immunol. 161: 6985-6992 [Abstract] [Full Text]
Wang, R.-F., Johnston, S. L., Zeng, G., Topalian, S. L., Schwartzentruber, D. J., Rosenberg, S. A. (1998). A Breast and Melanoma-Shared Tumor Antigen: T Cell Responses to Antigenic Peptides Translated from Different Open Reading Frames. J. Immunol. 161: 3596-3606 [Abstract] [Full Text]
Lupetti, R., Pisarra, P., Verrecchia, A., Farina, C., Nicolini, G., Anichini, A., Bordignon, C., Sensi, M., Parmiani, G., Traversari, C. (1998). Translation of a Retained Intron in Tyrosinase-related Protein (TRP) 2�mRNA Generates a New Cytotoxic T Lymphocyte (CTL)-defined and Shared Human Melanoma Antigen Not Expressed in Normal Cells of the Melanocytic Lineage. J. Exp. Med. 188: 1005-1016 [Abstract] [Full Text]
Tureci, O., Sahin, U., Zwick, C., Koslowski, M., Seitz, G., Pfreundschuh, M. (1998). Identification of a meiosis-specific protein as a member of the class of cancer/testis antigens. Proc. Natl. Acad. Sci. USA 95: 5211-5216 [Abstract] [Full Text]
Clynes, R., Takechi, Y., Moroi, Y., Houghton, A., Ravetch, J. V. (1998). Fc receptors are required in passive and active immunity�to�melanoma. Proc. Natl. Acad. Sci. USA 95: 652-656 [Abstract] [Full Text]
Wang, R.-F., Johnston, S. L., Southwood, S., Sette, A., Rosenberg, S. A. (1998). Recognition of an Antigenic Peptide Derived from Tyrosinase-Related Protein-2 by CTL in the Context of HLA-A31 and -A33. J. Immunol. 160: 890-897 [Abstract] [Full Text]
Specht, J. M., Wang, G., Do, M. T., Lam, J. S., Royal, R. E., Reeves, M. E., Rosenberg, S. A., Hwu, P. (1997). Dendritic Cells Retrovirally Transduced with a Model Antigen Gene Are Therapeutically Effective against Established Pulmonary Metastases. J. Exp. Med. 186: 1213-1221 [Abstract] [Full Text]
Osanto, S. (1997). Vaccine Trials for the Clinician: Prospects for Tumor Antigens. The Oncologist 2: 284-299 [Abstract] [Full Text]
Le Fur, N., Silvers, W. K., Kelsall, S. R., Mintz, B. (1997). Up-regulation of specific tyrosinase mRNAs in mouse melanomas with the c2j gene substituted for the wild-type tyrosinase allele: Utilization in design of syngeneic immunotherapy�models. Proc. Natl. Acad. Sci. USA 94: 7561-7565 [Abstract] [Full Text]
Wei, C., Willis, R. A., Tilton, B. R., Looney, R. J., Lord, E. M., Barth, R. K., Frelinger, J. G. (1997). Tissue-specific expression of the human prostate-specific antigen gene in transgenic mice: Implications for tolerance and�immunotherapy. Proc. Natl. Acad. Sci. USA 94: 6369-6374 [Abstract] [Full Text]
Le Fur, N., Kelsall, S. R., Silvers, W. K., Mintz, B. (1997). Selective increase in specific alternative splice variants of tyrosinase in murine melanomas: A projected basis for�immunotherapy. Proc. Natl. Acad. Sci. USA 94: 5332-5337 [Abstract] [Full Text]
Schmidt, W., Buschle, M., Zauner, W., Kirlappos, H., Mechtler, K., Trska, B., Birnstiel, M. L. (1997). Cell-free tumor antigen peptide-based�cancer�vaccines. Proc. Natl. Acad. Sci. USA 94: 3262-3267 [Abstract] [Full Text]
Chen, Y.-T., Scanlan, M. J., Sahin, U., Tureci, O., Gure, A. O., Tsang, S., Williamson, B., Stockert, E., Pfreundschuh, M., Old, L. J. (1997). A testicular antigen aberrantly expressed in human cancers detected by autologous antibody�screening. Proc. Natl. Acad. Sci. USA 94: 1914-1918 [Abstract] [Full Text]
Hishii, M., Andrews, D., Boyle, L.�A., Wong, J.�T., Pandolfi, F., van�den�Elsen, P.�J., Kurnick, J.�T. (1997). In vivo accumulation of the same anti-melanoma T cell clone in two different metastatic�sites. Proc. Natl. Acad. Sci. USA 94: 1378-1383 [Abstract] [Full Text]
Bloom, M. B., Perry-Lalley, D., Robbins, P. F., Li, Y., El-Gamil, M., Rosenberg, S. A., Yang, J. C. (1997). Identification of Tyrosinase-related Protein 2�as a Tumor Rejection Antigen for the B16 Melanoma. J. Exp. Med. 185: 453-460 [Abstract] [Full Text]
Wang, R.-F., Appella, E., Kawakami, Y., Kang, X., Rosenberg, S. A. (1996). Identification of TRP-2 as a Human Tumor Antigen Recognized by Cytotoxic T Lymphocytes. J. Exp. Med. 184: 2207-2216 [Abstract] [Full Text]
Zeng, G., Wang, X., Robbins, P. F., Rosenberg, S. A., Wang, R.-F. (2001). CD4+ T cell recognition of MHC class II-restricted epitopes from NY-ESO-1 presented by a prevalent HLA DP4 allele: Association with NY-ESO-1 antibody production. Proc. Natl. Acad. Sci. USA 98: 3964-3969 [Abstract] [Full Text]